Here's what we'll cover Key takeaways The FDA-approved starting dose of semaglutide for weight loss is 0.25 mg weekly, and the maximum dose of semaglutide for weight loss is 2.4 mg weekly
In one of the focus groups, there was no disagreement when one participant asked, [d]oes it feel almost inevitable that those drugs are going to become part of our formulary? Our insurance provider, Cigna told us that within the next 9 to 12 months, theres really not going to be a choice, that all insurance companies are probably going to be covering GLP-1s for weight loss. Occupational health manager, large manufacturer The use of GLP-1 drugs for weight loss is still new for many employers, and many are not sure how or whether they can manage the benefit
GLP-1 options include Wegovy pill or pen, Mounjaro, Ozempic, Zepbound pen or vial, and Foundayo pills
During the phase 3 trial of tirzepatide, 6.6% of patients discontinued the medication due to side effects [114]